InvestorsHub Logo

gerry57

10/09/23 4:42 PM

#434684 RE: Investor2014 #434683

Thanks not really sure how off label works, Parkinson’s with cognitive decline perhaps, als with nfl elevation and so on, ways around the label( assuming they measured nfl biomarker as it will almost certainly become a surrogate)thanx

WilliamMunny

10/09/23 4:53 PM

#434685 RE: Investor2014 #434683

Just to put it in some perspective, can you tell us what the AD subgroup labelling is for Lecanemab (aka LEQEMBI)?